Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Prior to the Annual General Meeting (AGM) in 2024, that will take place on April 26, a Nomination Committee has been appointed. The shareholders...
Election of new member of the board of directors The extraordinary general meeting in Orexo AB (publ) on 26 October 2023 resolved, in accordance with ...
The six-month randomized controlled trial (RCT) enrolled 437 participants at 36 sites across the US The study demonstrated no statistically...
Orexo AB (publ), Reg. No. 556500-0600, with its registered office in Uppsala, gives notice of the Extraordinary General Meeting to be held on 26...
Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), today announces the submission of the New Drug Application (NDA) to the US Food and Drug Administration...
Orexo AB (Publ.), (STO:ORX) (OTCQX:ORXOY), today announces the company will participate in Pareto Securities' 14th Annual Healthcare Conference, that ...
Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY) today announces that the United States Patent and Trademark Office (USPTO) has granted the first US...
Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), today announces that Sun Pharmaceutical Industries Limited, Sun Pharma Global FZE, Sun Pharma Global,...
The patent win critical enabler for future growth Q2 2023 highlights › Total net revenues of SEK 157.7 m (147.8) › EBITDA of SEK 5.6 m (-32.5),...
Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), today announces that the US District Court for the District of New Jersey ruled in favor of Orexo in its ...
Focusing operations on Orexo´s strengths Q1 2023 highlights Total net revenues of SEK 158.8 m (159.4) EBITDA of SEK -41.1 m (2.8), EBITDA excluding...
Election of the board of directors and auditor The annual general meeting in Orexo AB (publ) on 18 April 2023 resolved, in accordance with the...
Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), today announces the expected US launch of OX124, a high-dose rescue medication for opioid overdose, is...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.